课题基金 / 基金详情

Regulated intramembrane proteolysis of transferrin receptor 1 and the role of the released intracellular domain in singaling of iron metabolism

Regulated intramembrane proteolysis of transferrin receptor 1 and the role of the released intracellular domain in singaling of iron metabolism
转铁蛋白受体 1 的膜内蛋白水解调节以及释放的胞内结构域在铁代谢信号传导中的作用
批准号:
73952010
负责人:
Professor Dr. Hendrik Fuchs
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2010-12-31

项目摘要

项目成果

Professor Dr. Hendrik Fuchs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The understanding of the pathogenesis of hemochromatosis and other diseases of iron metabolism requires knowledge of the molecular regulation mechanism to retain systemic iron homeostasis. Transferrin receptor 1 (TfR1) regulates iron uptake into the cell. Ist ectodomain is released into the serum. As far as is known no function has been assigned to this soluble form of TfR1 to date emphasizing the role of the intracellular located TfR1-N-terminal fragment. As shown in our peliminary work, the intracellular fragment is further cleaved by an intramembrane cleaving protease (I-CLiP). Intramembrane proteolysis promotes the release of intracellular signal molecules and transcription factors. Aim of the project is thus to characterize the role of TfR1 intramembrane proteolysis and of the released intracellular domain (ICD) for the molecular regulation of systemic iron homeostasis. This will be achieved by identification of the I-CLiP-protease, investigations on the regulation of proteolysis as well as by studies on ICD trafficking and ist final localization. Furthermore, identification of interaction partners within the involved compartments is of great importance. Therefore, the ICD will be accumulated by proteasome inhibition and recombinant expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-inflammatory glycosides from plants: Identification of cellular targets and examination of structure–function relationships
Development of tumor-activated targeted toxins and their investigation in combination with glycosylated triterpenoids
Development of a novel strategy for cancer therapy by combining chimeric adaptertoxins and triterpenoids investigated on mammary gland tumors.
Identifizierung und Charakterisierung der Arg-100-Transferrinrezeptor-Sheddingprotease
海外基金